Literature DB >> 25876528

The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation.

Jelena Kornej1, Gerhard Hindricks2, M Benjamin Shoemaker3, Daniela Husser2, Arash Arya2, Philipp Sommer2, Sascha Rolf2, Pablo Saavedra3, Arvindh Kanagasundram3, S Patrick Whalen3, Jay Montgomery3, Christopher R Ellis3, Dawood Darbar3, Andreas Bollmann2.   

Abstract

BACKGROUND: Recurrent atrial fibrillation (AF) occurs in up to 50 % of patients within 1 year after catheter ablation, and a clinical risk score to predict recurrence remains a critical unmet need. The aim of this study was to (1) develop a simple score for the prediction of rhythm outcome following catheter ablation; (2) compare it with the CHADS2 and CHA2DS2-VASc scores, and (3) validate it in an external cohort.
METHODS: Rhythm outcome between 3 and 12 months after AF catheter ablation were documented. The APPLE score [one point for age >65 years, persistent AF, impaired eGFR (<60 ml/min/1.73 m(2)), LA diameter ≥43 mm, EF < 50 %] was associated with AF recurrence and was validated in an external cohort in 261 patients with comparable ablation and follow-up.
RESULTS: In 1145 patients (60 ± 10 years, 65 % male, 62 % paroxysmal AF) the APPLE score showed better prediction of AF recurrences (AUC 0.634, 95 % CI 0.600-0.668, p < 0.001) than CHADS2 (AUC 0.538) and CHA2DS2-VASc (AUC 0.542). Compared to patients with an APPLE score of 0, the odds ratio for AF recurrences was 1.73, 2.79 and 4.70 for APPLE scores 1, 2, or ≥3, respectively (all p < 0.05). In the external validation cohort, the APPLE score showed similar results (AUC 0.624, 95 % CI 0.562-0.687, p < 0.001).
CONCLUSIONS: The novel APPLE score is superior to the CHADS2 and CHA2DS2-VASc scores for prediction of rhythm outcome after catheter ablation. It holds promise as a useful tool to identify patients with low, intermediate, and high risk for AF recurrence.

Entities:  

Keywords:  AF recurrences; Atrial fibrillation; Catheter ablation; Risk scores

Mesh:

Year:  2015        PMID: 25876528      PMCID: PMC4726453          DOI: 10.1007/s00392-015-0856-x

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  16 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

Review 3.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Authors:  Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

4.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

5.  Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up.

Authors:  Tze-Fan Chao; Hsuan-Ming Tsao; Yenn-Jiang Lin; Chin-Feng Tsai; Wei-Shiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Kazuyoshi Suenari; Cheng-Hung Li; Beny Hartono; Hung-Yu Chang; Kibos Ambrose; Tsu-Juey Wu; Shih-Ann Chen
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-05-01

6.  Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry.

Authors:  Jelena Kornej; Jedrzej Kosiuk; Gerhard Hindricks; Arash Arya; Philipp Sommer; Sascha Rolf; Daniela Husser; Gregory Y H Lip; Andreas Bollmann
Journal:  Clin Res Cardiol       Date:  2015-02-24       Impact factor: 5.460

7.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

8.  Efficacy of catheter ablation of atrial fibrillation beyond HATCH score.

Authors:  Ri-Bo Tang; Jian-Zeng Dong; De-Yong Long; Rong-Hui Yu; Man Ning; Chen-Xi Jiang; Cai-Hua Sang; Xiao-Hui Liu; Chang-Sheng Ma
Journal:  Chin Med J (Engl)       Date:  2012-10       Impact factor: 2.628

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  pROC: an open-source package for R and S+ to analyze and compare ROC curves.

Authors:  Xavier Robin; Natacha Turck; Alexandre Hainard; Natalia Tiberti; Frédérique Lisacek; Jean-Charles Sanchez; Markus Müller
Journal:  BMC Bioinformatics       Date:  2011-03-17       Impact factor: 3.307

View more
  53 in total

Review 1.  Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Falco Kosich; Katja Schumacher; Tatjana Potpara; Gregory Y Lip; Gerhard Hindricks; Jelena Kornej
Journal:  Clin Cardiol       Date:  2019-01-14       Impact factor: 2.882

Review 2.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

3.  Ablation of very late recurrence after initially successful ablation of atrial fibrillation.

Authors:  Jonathan S Steinberg; Yash Shah; Barbara Szepietowska
Journal:  Clin Res Cardiol       Date:  2017-12-06       Impact factor: 5.460

4.  Catheter ablation of paroxysmal atrial fibrillation: circumferential pulmonary vein ablation: success rates with and without exclusion of areas adjacent to the esophagus.

Authors:  Klaus Kettering; Dag-Hau Yim; Alexander Benz; Felix Gramley
Journal:  Clin Res Cardiol       Date:  2017-05-10       Impact factor: 5.460

5.  Risk factors for recurrence of atrial fibrillation.

Authors:  Antoniya Kisheva; Yoto Yotov
Journal:  Anatol J Cardiol       Date:  2021-05       Impact factor: 1.596

6.  Patient characteristics as predictors of recurrence of atrial fibrillation following cryoballoon ablation.

Authors:  Aakash A Bavishi; Rachel M Kaplan; Graham Peigh; Celso L Diaz; Jayson R Baman; Amar Trivedi; Jeremiah Wasserlauf; Mark J Shen; Prasongchai Sattayaprasert; Alexandru B Chicos; Susan Kim; Nishant Verma; Rishi Arora; Albert Lin; Bradley P Knight; Rod S Passman
Journal:  Pacing Clin Electrophysiol       Date:  2019-04-09       Impact factor: 1.976

Review 7.  [Biomarkers and atrial fibrillation : Prediction of recurrences and thromboembolic events after rhythm control management].

Authors:  Jelena Kornej; Katja Schumacher; Daniela Husser; Gerhard Hindricks
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-14

8.  Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation.

Authors:  Christian Pfluecke; Daniel Tarnowski; Lina Plichta; Katharina Berndt; Paul Schumacher; Stefan Ulbrich; Mathias Forkmann; Marian Christoph; David M Poitz; Carsten Wunderlich; Ruth H Strasser; Karim Ibrahim
Journal:  Clin Res Cardiol       Date:  2015-09-28       Impact factor: 5.460

9.  Recurrence of Atrial Fibrillation in Dependence of Left Atrial Volume Index.

Authors:  Malte Kranert; Tetyana Shchetynska-Marinova; Volker Liebe; Christina Doesch; Theano Papavassiliu; Ibrahim Akin; Martin Borggrefe; Anna Hohneck
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

10.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.